Microfluidics-based diagnostics of infectious diseases in the developing world.

Area of Science:

• Biomedical Engineering
• Infectious Disease Diagnostics
• Microfluidics

Background:

• Developing accessible healthcare technologies for underserved populations is a critical global challenge.
• Existing diagnostic methods often require complex laboratory infrastructure and trained personnel, limiting their use in resource-limited settings.

Purpose of the Study:

• To develop an integrated microfluidic point-of-care (POC) assay that simplifies complex laboratory procedures like ELISA.
• To create a low-cost, user-friendly diagnostic tool for early detection of infectious diseases in remote areas.

Main Methods:

• Integration of microfluidic manufacturing, fluid handling, and signal detection into a single assay (mChip).
• Utilized microfluidics and nanoparticles for assay miniaturization and enhanced sensitivity.
• Conducted field testing in Rwanda using locally collected human samples.

Main Results:

• The mChip assay accurately diagnosed HIV from 1 μl of unprocessed whole blood.
• Simultaneous diagnosis of HIV and syphilis was achieved with performance comparable to reference benchtop assays.
• The mChip test eliminates the need for subjective user interpretation of results.

Conclusions:

• The developed mChip assay represents an integrated microfluidic strategy for effective POC diagnostics.
• This technology enables early detection of infectious diseases, significantly improving healthcare accessibility in remote and underserved regions.
• The mChip assay offers a cost-effective and reliable solution for global health challenges.